Alvotech (ALVO) Cash & Current Investments (2020 - 2026)
Alvotech's (ALVO) quarterly Cash & Current Investments came in at $142.8 million in Q2 2026, down 5.75% on a YoY basis from $151.5 million in Q2 2025, and up 123.63% quarter-over-quarter from $63.8 million in Q1 2026.
Analysis
Alvotech (ALVO) Cash & Current Investments (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Cash & Current Investments for 7 consecutive years, with $142.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Current Investments fell 5.75% year-over-year to $142.8 million; the trailing twelve-month figure through Jun 2026 stood at $142.8 million (down 5.75% YoY), and the FY2025 full-year result was $172.4 million, up 235.15% from the prior year.
- Cash & Current Investments rose to $142.8 million in Q2 2026 per ALVO's latest filing, from $63.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $172.4 million in Q4 2025 and bottomed at $10.9 million in Q2 2024.
- Historically, Cash & Current Investments has averaged $81.8 million across 5 years, with a median of $64.3 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Cash & Current Investments plunged 83.2% in 2023, then soared 1283.88% in 2025.
- Over 5 years, Cash & Current Investments stood at $66.4 million in 2022, then plunged by 83.2% to $11.2 million in 2023, then jumped by 360.95% to $51.4 million in 2024, then surged by 235.15% to $172.4 million in 2025, then decreased by 17.18% to $142.8 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $142.8 million, $63.8 million, and $172.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 3.66 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 886.50 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 171.67 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 127.64 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 1.84 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 360.25 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 142.75 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 290.12 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 41.25 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 3.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.75 Mn |
| Mar 31, 2026 | 63.83 Mn |
| Dec 31, 2025 | 172.36 Mn |
| Sep 30, 2025 | 51.43 Mn |
| Jun 30, 2025 | 151.45 Mn |
| Mar 31, 2025 | 51.43 Mn |
| Dec 31, 2024 | 51.43 Mn |
| Sep 30, 2024 | 118.27 Mn |
| Jun 30, 2024 | 10.94 Mn |
| Mar 31, 2024 | 64.81 Mn |
| Dec 31, 2023 | 11.16 Mn |
| Jun 30, 2023 | 60.47 Mn |
| Dec 31, 2022 | 66.43 Mn |
| Jun 30, 2022 | 128.44 Mn |
| Dec 31, 2021 | 17.56 Mn |
| Dec 31, 2020 | 31.69 Mn |